Kim Zeller

Synthesis and Structure−Activity Relationships of 8-(Pyrid-3-yl)pyrazolo[1,5-<i>a</i>]-1,3,5-triazines: Potent, Orally Bioavailable Corticotropin Releasing Factor Receptor-1 (CRF₁) Antagonists

Paul J. Gilligan, Todd Clarke, Liqi He et al. · Journal of Medicinal Chemistry · 2009 · 58 citations · Full text

Receptor Antagonists, Psychopharmacology, Compound 13-15 +17

Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

Snježana Lelas, Harvey Wong, Yu-Wen Li et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 55 citations

Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator

Nathan Spear, R.A. Gadient, Deidre Wilkins et al. · European Journal of Pharmacology · 2011 · 43 citations

Functional Selectivity, Medicine, Neurotransmitter +9

The CRF 1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats

John Mcelroy, Kim Zeller, Keith Jones et al. · Psychopharmacology · 2002 · 42 citations

Adrenal Gland, Stress Hormone, Crf 1 +13

In vivo agonist properties of 7‐hydroxy‐N,N‐di‐n‐propyl‐2‐aminotetralin, a dopamine D₃‐selective receptor ligand

John Mcelroy, Kim Zeller, Kelly Amy et al. · Drug Development Research · 1993 · 16 citations

Psychopharmacology, Locomotor Activity, Pharmacotherapy +16